Sfoglia per AUTORE
RADIN M
Collezione ASL Città di Torino

  

Items : 114

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Oct 18:keae583. doi: 10.1093/rheumatology/keae583.
2024
ASL Città di Torino

Cecchi I; Radin M; Foddai SG; Barinotti A; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Lopez Pedrera C; Fortin PR; Gerosa M; de Jesus G; Atsumi T; Ji L; Efthymiou M; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri M; Cervera R; Knight J; Artim-Esen B; Willis R; Bertolaccini ML; Cohen H; Erkan D; Sciascia S;

2023 ACR/EULAR classification criteria in existing research cohorts: an international study. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Oct 1;63(10):2770-2775. doi: 10.1093/rheumatology/keae058.
2024
ASL Città di Torino

Sciascia S; Roccatello D; Rossi D; Gimen Alonso C; Alba P; Rubini E; Barinotti A; Radin M; Cecchi I; Foddai SG;

Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.
2024
ASL Città di Torino
AOU Città della Salute di Torino

Sciascia S; Roccatello D; Barinotti A; Menegatti E; Baldovino S; Foddai SG; Cioffi M; Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L;

Differential biologic response between venous and microvascular endothelium exposed to Antiphospholipid Syndrome (APS) patients' serum. in Vascular pharmacology / Vascul Pharmacol. 2024 Jun;155:107296. doi: 10.1016/j.vph.2024.107296.
2024
ASL Città di Torino

Arrigo E; Marinotti C; Shelton-Agar FMA; Barinotti A; Radin M; Sciascia S; Mancardi D;

2024
ASL Città di Torino

Versino E; Lembo D; Roccatello D; Sciascia S; Olugbogi A; Tesio N; Ugo H; Zanetti E; Zevallos C; Campa L; Gazzola V; Aluf O; Parente S; Radin M;

Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review. in Immunologic research / Immunol Res. 2024 Aug;72(4):538-553. doi: 10.1007/s12026-024-09463-y. Epub 2024 Mar 9.
2024
ASL Città di Torino

Roccatello D; Fenoglio R; Barinotti A; Cecchi I; Radin M; Foddai SG; Arbrile M; Sciascia S;

Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation. in Frontiers in immunology / Front Immunol. 2024 Mar 14;15:1351446. doi: 10.3389/fimmu.2024.1351446. eCollection 2024.
2024
ASL Città di Torino

Sciascia S; Rodríguez-Carrio J; Roccatello D; Suárez A; Foddai SG; Menegatti E; Radin M; Barinotti A; Cecchi I;

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.
2023
ASL Città di Torino

Roccatello D; Menegatti E; Baldovino S; Barinotti A; Guidetti MG; Cinnirella G; Crosasso P; Cecchi I; Radin M; Foddai SG; Fenoglio R; Rilat MLA; Sciascia S;

Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-?2GPI I domain. in Autoimmunity reviews / Autoimmun Rev. 2023 Nov;22(11):103454. doi: 10.1016/j.autrev.2023.103454. Epub 2023 Sep 22.
2023
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Elnaz R; Rubini E; Aluf O; Barinotti A; Cecchi I; Radin M; Manfredi M; Benucci M; Infantino M; Foddai S;

2023
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Bentow C; Rossi D; Mahler M; Miraglia P; Arbrile M; Wilson Jones G; Barinotti A; Radin M; Cecchi I;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino

Roccatello D; Menegatti E; Vaccarino A; Fenoglio R; Rossi D; Rubini E; Barinotti A; Cecchi I; Radin M; Sciascia S;

Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases. in Autoimmunity reviews / Autoimmun Rev. 2023 Jul;22(7):103351. doi: 10.1016/j.autrev.2023.103351. Epub 2023 Apr 28.
2023
ASL Città di Torino

Roccatello D; Husum D; Schreiber K; Radin M; Ricceri F; Sciullo A; Cioffi M; Padovan D; Sciascia S; Gilcrease GW; Nikiphorou E;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.
2023
ASL Città di Torino

Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;

"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach. in European journal of internal medicine / Eur J Intern Med. 2023 Jan;107:1-6. doi: 10.1016/j.ejim.2022.10.010. Epub 2022 Oct 20.
2023
ASL Città di Torino

Sciascia S; Roccatello D; Pengo V; Morotti A; Rubini E; Barinotti A; Arbrile M; Foddai SG; Radin M; Cecchi I;

Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review. in International journal of molecular sciences / Int J Mol Sci. 2023 Feb 3;24(3):3041. doi: 10.3390/ijms24033041.
2023
ASL Città di Torino

Roccatello D; Menegatti E; Barinotti A; Foddai SG; Rilat L; Cecchi I; Miraglia P; Medica D; Arbrile M; Radin M; Sciascia S;

The role of bacteria and viruses in Behçet syndrome: Should we move towards new paradigms? in Autoimmunity reviews / Autoimmun Rev. 2023 Feb;22(2):103237. doi: 10.1016/j.autrev.2022.103237. Epub 2022 Nov 19.
2023
ASL Città di Torino

Lembo D; Civra A; Radin M; Roccatello D; Trunfio M; Calcagno A; Arbrile M; Sciascia S;

Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies. in Autoimmunity reviews / Autoimmun Rev. 2023 Dec;22(12):103467. doi: 10.1016/j.autrev.2023.103467. Epub 2023 Oct 17.
2023
ASL Città di Torino

Chighizola CB; Andreoli L; Sciascia S; Tamborini F; Roccatello D; Moroni G; Reyes-Navarro GV; Iaccarino L; Larosa M; Saavedra MÁ; Crisafulli F; Klumb EM; de Jesús GR; Lacerda MI; Radin M; Cecchi I;

Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies. in Journal of clinical pathology / J Clin Pathol. 2023 Dec;76(12):839-846. doi: 10.1136/jcp-2022-208199. Epub 2022 Sep 13.
2023
ASL Città di Torino

Sciascia S; Menegatti E; Roccatello D; Rubini E; Foddai SG; Cecchi I; Barinotti A; Radin M;

16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends. in Lupus / Lupus. 2023 Dec;32(14):1625-1636. doi: 10.1177/09612033231211820. Epub 2023 Nov 7.
2023
ASL Città di Torino

Atsumi T; Chighizola CB; Fujieda Y; Mackie I; Radin M; Roubey R; Bertolaccini ML;

Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease. in BMC rheumatology / BMC Rheumatol. 2023 Apr 5;7(1):6. doi: 10.1186/s41927-023-00330-1.
2023
AOU Città della Salute di Torino
ASL Città di Torino

Lanzetta I; Fenoglio R; Menegatti E; Roccatello D; Charbonier N; Barreca A; Cecchi I; Sciascia S; Giarin M; Radin M; Miraglia P;

Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies. in Kidney international reports / Kidney Int Rep. 2023 Jan 23;8(4):754-763. doi: 10.1016/j.ekir.2023.01.018. eCollection 2023 Apr.
2023
ASL Città di Torino
AOU Città della Salute di Torino

Barreca A; Caroti L; Roccatello D; Fenoglio R; Sciascia S; De Simone E; Cecchi I; Emmi G; Cuadrado MJ; Radin M; Becker JU; Seshan SV; Andrade D; Moroni G; Yazdany J; Innocenti S;

2023
ASL Città di Torino

Infantino M; Foddai S; Manfredi M; Benucci M; Radin M; Cecchi I; Barinotti A; Aluf O; Rubini E; Elnaz R; Menegatti E; Roccatello D; Sciascia S;

2023
ASL Città di Torino

Foddai SG; Radin M; Schreiber K; Cecchi I; Signorelli F; De Jesùs G; Aso K; Kono M; Urban ML; Bacco B; Gallo Cassarino S; Lo Sardo L; Arbrile M; Barinotti A; Gómez-García I; Quaglia MI; Tissera Y; Gervaso F; Aguirre-Zamorano MÁ; Alba P; Benedetto C; Atsumi T; Amengual O; Emmi G; Andrade D; Marozio L; Roccatello D; Sciascia S;

Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head. in International journal of cardiology / Int J Cardiol. 2022 Sep 15;363:185-189. doi: 10.1016/j.ijcard.2022.06.040. Epub 2022 Jun 14.
2022
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Rubini E; Arbrile M; Foddai SG; Cecchi I; Radin M; Barinotti A;

Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.
2022
ASL Città di Torino

Truglia S; Urban ML; Sebastiani GD; Ramoni VL; Rubini E; Raffeiner B; Pazzola G; Radin M; Nalli C; Lazzaroni MG; Hoxha A; Larosa M; Gerosa M; Franceschini F; Fischetti F; Fioravanti A; Emmi G; Conti F; Chighizola CB; Cecchi I; Carubbi F; Canti V; Calligaro A; Barinotti A; Andreoli L; Alunno A; Alessandri C; Foddai SG; Sciascia S; et alii...

Pregnancy outcomes in Behçet's disease: Results from a monocentric cohort. in Journal of reproductive immunology / J Reprod Immunol. 2022 Sep;153:103682. doi: 10.1016/j.jri.2022.103682. Epub 2022 Aug 1.
2022
ASL Città di Torino

Sciascia S; Roccatello D; Menegatti E; Rossi D; Radin M; Arbrile M;

Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):1612-1620. doi: 10.1055/a-1798-2400. Epub 2022 Mar 15.
2022
ASL Città di Torino

Tincani A; Roccatello D; Urban ML; Sebastiani GD; Truglia S; Rubini E; Raffeiner B; Radin M; Ramoni VL; Nalli C; Pazzola G; Lazzaroni MG; Larosa M; Gerosa M; Hoxha A; Franceschini F; Fischetti F; Emmi G; Fioravanti A; Chighizola CB; Conti F; Cecchi I; Canti V; Carubbi F; Calligaro A; Andreoli L; Barinotti A; Alessandri C; Alunno A; et alii...

Renal Fibrosis in Lupus Nephritis. in International journal of molecular sciences / Int J Mol Sci. 2022 Nov 18;23(22):14317. doi: 10.3390/ijms232214317.
2022
ASL Città di Torino

Roccatello D; Rossi D; Wilson Jones G; Mancardi D; Fenoglio R; Cecchi I; Radin M; Barinotti A; Cozzi M; Sciascia S;

Serum Biomarkers of Renal Fibrosis: A Systematic Review. in International journal of molecular sciences / Int J Mol Sci. 2022 Nov 16;23(22):14139. doi: 10.3390/ijms232214139.
2022
ASL Città di Torino

Sciascia S; Roccatello D; Rubini E; Foddai SG; Cecchi I; Radin M; Barinotti A;

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience. in Journal of clinical medicine / J Clin Med. 2022 May 25;11(11):2977. doi: 10.3390/jcm11112977.
2022
ASL Città di Torino

Roccatello D; Fenoglio R; Baldovino S; Rossi D; Terzolo E; Menegatti E; Cecchi I; Radin M; Barinotti A; Sciascia S;

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.
2022
ASL Città di Torino

Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;

Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. in Nature reviews. Rheumatology / Nat Rev Rheumatol. 2022 Jan;18(1):9-21. doi: 10.1038/s41584-021-00710-2. Epub 2021 Nov 11.
2022
ASL Città di Torino

Pons-Estel G; Mosca M; Yazdany J; Parodis I; Roccatello D; Radin M; Sciascia S;

Quality of life measures in Systemic Lupus Erythematosus: A systematic review. in Reumatismo / Reumatismo. 2022 Feb 7;73(4). doi: 10.4081/reumatismo.2021.1447.
2022
ASL Città di Torino

Uthman I; Taher A; Roccatello D; Barinotti A; Radin M; El Hasbani G; Sciascia S;

Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2022 Dec;57:152113. doi: 10.1016/j.semarthrit.2022.152113. Epub 2022 Oct 22.
2022
AO Ordine Mauriziano
ASL Città di Torino

Sciascia S; Roccatello D; Marozio L; Andrade D; Emmi G; Amengual O; Atsumi T; Benedetto C; Alba P; Aguirre-Zamorano MÁ; Gervasoni F; Tissera Y; Quaglia MI; Gómez-García I; Barinotti A; Foddai SG; Lo Sardo L; Gallo Cassarino S; Bacco B; Urban ML; Kono M; Aso K; de Jesús G; Signorelli F; Cecchi I; Schreiber K; Radin M;

Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2022 Aug 22;12(8):2026. doi: 10.3390/diagnostics12082026.
2022
ASL Città di Torino

Mahler M; Roccatello D; Foddai S; Cecchi I; Barinotti A; Radin M; Bentow C; Sciascia S;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
2022
ASL Città di Torino

Sciascia S; Roccatello D; Rossi D; Menegatti E; Baldovino S; Barinotti A; Favuzzi MD; Crosasso P; Milone V; Osella S; Di Gregorio F; Di Nunzio P; Buccarano N; Arbrile M; Cecchi I; Radin M;

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2022 Sep 12;13:957201. doi: 10.3389/fimmu.2022.957201. eCollection 2022.
2022
ASL Città di Torino

Serrano A; Pleguezuelo D; Serrano M; Shoenfeld Y; Benucci M; Cecchi I; Radin M; Roccatello D; Saponjski J; Regola F; Stanisavljevic N; Milanovic M; Manfredi M; Garcinuño S; Kostyra-Grabczak K; Infantino M; Sciascia S; Ma?li?ska M; Tincani A; Djokovic A; Andreoli L; Naranjo L; Stojanovich L;

Renal involvement as a unique manifestation of hemophagocytic syndrome. in Frontiers in medicine / Front Med (Lausanne). 2022 Oct 5;9:796121. doi: 10.3389/fmed.2022.796121. eCollection 2022.
2022
ASL Città di Torino
AOU Città della Salute di Torino

Fenoglio R; Radin M; Quattrocchio G; Naretto C; Alpa M; Barreca A; Sciascia S; Roccatello D;

The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1071-1076. doi: 10.55563/clinexprheumatol/c96ief. Epub 2020 N
2021
ASL Città di Torino

Sciascia S; Cuadrado MJ; Jacobsen S; Roccatello D; Rubini E; Cecchi I; Radin M; Schreiber K;

Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study). in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):938-946. doi: 10.55563/clinexprheumatol/2b73dn. Epub 2020 Sep
2021
ASL Città di Torino
AOU Città della Salute di Torino

Alunno A; Quartuccio L; Ramoni V; Bellis E; Sainaghi PP; Sciascia S; Pregnolato F; Coletto LA; Praino E; Radin M; Costa L; Baldi C; Monti S; Bellan M; Carubbi F; Hoxha A; Gerosa M; Crisafulli F; Chighizola CB; Andreoli L;

Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS). in European journal of internal medicine / Eur J Intern Med. 2021 Oct;92:134-136. doi: 10.1016/j.ejim.2021.07.004. Epub 2021 Jul 28.
2021
ASL Città di Torino

Sciascia S; Roccatello D; Cecchi I; Foddai SG; Radin M;

Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.
2021
ASL Città di Torino

Roccatello D; Barinotti A; Foddai SG; Rubini E; Radin M; Cecchi I; Sciascia S;

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.
2021
AOU Città della Salute di Torino
ASL Città di Torino
AO Ordine Mauriziano

Mengozzi G; Roccatello D; Rossi D; Giachino O; Baldovino S; Vaccarino A; Bazzan M; Rubini E; Bertero MT; Bertolaccini ML; Cecchi I; Sciascia S; Radin M;

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.
2021
ASL Città di Torino

Roccatello D; Sciascia S; Rubini E; Barinotti A; Cecchi I; Foddai SG; Radin M;

2021
ASL Città di Torino

Sciascia S; Casas S; Roccatello D; Mahler M; Seaman A; Ramirez C; Barinotti A; Rubini E; Cecchi I; Radin M; Foddai S;

16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. in Lupus / Lupus. 2021 Jul;30(8):1314-1326. doi: 10.1177/09612033211020361. Epub 2021 May 27.
2021
ASL Città di Torino

Erkan D; Levy RA; Cecchi I; Radin M; Sciascia S;

Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players? in European journal of clinical investigation / Eur J Clin Invest. 2021 Feb;51(2):e13441. doi: 10.1111/eci.13441. Epub 2020 Nov 15.
2021
ASL Città di Torino

Roccatello D; Fenoglio R; Cecchi I; Radin M; Cozzi M; Arrigo E; Mancardi D; Sciascia S;

2021
ASL Città di Torino
AOU Città della Salute di Torino
AO Ordine Mauriziano

Bertero T; Govoni M; Benedetto C; Andrade D; Franceschini F; Gallo Cassarino S; Padovan M; Foddai SG; Rubini E; Bacco B; de Freitas CM; Crisafulli F; Bortoluzzi A; Cecchi I; Radin M; Schreiber K; Marozio L; Roccatello D; Andreoli L; Sciascia S;

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies. in The Lancet. Rheumatology / Lancet Rheumatol. 2021 Dec;3(12):e832. doi: 10.1016/S2665-9913(21)00320-9. Epub 2021 Oct 20.
2021
ASL Città di Torino

Cecchi I; Baldovino S; Vaccarino A; Pini M; Schreiber K; Costanzo P; Radin M; Sciascia S; Roccatello D;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.
2021
ASL Città di Torino

Sciascia S; Menegatti E; Roccatello D; Rubini E; Cecchi I; Barinotti A; Foddai SG; Radin M;

Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets. in Expert review of clinical immunology / Expert Rev Clin Immunol. 2021 Apr;17(4):395-406. doi: 10.1080/1744666X.2021.1901581. Epub 2021 Mar 3
2021
ASL Città di Torino

Sciascia S; Knight JS; Tambralli A; Rodríguez-Carrio J; Radin M; Cecchi I;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.
2021
ASL Città di Torino

Roccatello D; Vaccarino A; Rossi D; Barinotti A; Foddai SG; Rubini E; Cecchi I; Radin M; Sciascia S;

2021
ASL Città di Torino

Sciascia S; Cuadrado MJ; Jacobsen S; Roccatello D; Cecchi I; Rubini E; Schreiber K; Radin M;

Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. in American journal of nephrology / Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13.
2021
ASL Città di Torino

Roccatello D; Fenoglio R; Barinotti A; Miraglia P; Radin M; Sciascia S;

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove. in Frontiers in immunology / Front Immunol. 2021 Jun 16;12:687534. doi: 10.3389/fimmu.2021.687534. eCollection 2021.
2021
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bacco B; Norbiato C; Bertero MT; Carignola R; Cosseddu D; Montaruli B; Bazzan M; Radin M; Sciascia S; Gallo Cassarino S; Roccatello D;

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.
2021
ASL Città di Torino

Roccatello D; Sciascia S; Baldovino S; Menegatti E; Rossi D; Radin M; Arbrile M;

A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2020 Sep 1;59(9):2412-2418. doi: 10.1093/rheumatology/kez620.
2020
ASL Città di Torino
AOU Città della Salute di Torino
AO Ordine Mauriziano

Roccatello D; Marozio L; Bertero T; Govoni M; Benedetto C; Franceschini F; Andrade D; Gallo Cassarino S; Padovan M; Foddai SG; Rubini E; Bacco B; de Freitas CM; Crisafulli F; Bortoluzzi A; Schreiber K; Cecchi I; Radin M; Andreoli L; Sciascia S;

Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome. in Autoimmunity reviews / Autoimmun Rev. 2020 Oct;19(10):102641. doi: 10.1016/j.autrev.2020.102641. Epub 2020 Aug 13.
2020
ASL Città di Torino

Mahler M; Roccatello D; Menegatti E; Fenoglio R; Baldovino S; Foddai SG; Rubini E; Cecchi I; Casas S; Bentow C; Seaman A; Ramirez C; Radin M; Sciascia S;

Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis. in Current opinion in obstetrics & gynecology / Curr Opin Obstet Gynecol. 2020 Oct;32(5):351-358. doi: 10.1097/GCO.0000000000000649.
2020
ASL Città di Torino

Schreiber K; Frishman M; Radin M;

Antiphospholipid Syndrome Is Still a Rare Disease-Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2020 Oct;72(10):1774-1776. doi: 10.1002/art.41401. Epub 2020 Sep 6.
2020
ASL Città di Torino

Roccatello D; Rubini E; Cecchi I; Vaccarino A; Montaruli B; Montabone E; Carignola R; Bertero T; Bazzan M; Sciascia S; Radin M; Baldovino S;

The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities. in Journal of thrombosis and haemostasis : JTH / J Thromb Haemost. 2020 Nov;18(11):2921-2928. doi: 10.1111/jth.15053. Epub 2020 Sep 21.
2020
ASL Città di Torino
AOU Città della Salute di Torino

Marozio L; Benedetto C; Donati Marello B; Roccatello D; Manetta T; Mengozzi G; Menegatti E; Barinotti A; Orpheu G; Rubini E; Gaito S; Cecchi I; Radin M; Foddai SG; Sciascia S;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino

Roccatello D; Oddone V; Osella S; Piccioni P; Radin M; Navarra M; Natale G; Milone V; Massara C; Manno E; Livigni S; Giusti M; Imperiale D; Imperiale G; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Cozzi M; Converso M; Cinnirella G; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Baldovino S; Rossi D; et alii...

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study. in International journal of environmental research and public health / Int J Environ Res Public Health. 2020 May 15;17(10):3469. doi: 10.3390/ijerph17103469.
2020
ASL Città di Torino

Rossi D; Roccatello D; Baldovino S; Foddai SG; Rubini E; Crosasso P; Favuzzi MD; Osella S; Valeria M; Di Gregorio F; Buccarano N; Di Nunzio P; Cecchi I; Radin M; Sciascia S;

Filling the gap in antiphospholipid syndrome diagnosis: a patient's story. in Lupus / Lupus. 2020 Mar;29(3):236-238. doi: 10.1177/0961203320903810. Epub 2020 Jan 29.
2020
ASL Città di Torino

Roccatello D; Baldovino S; Radin M; Sciascia S;

Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2020 Jun;50(3):553-556. doi: 10.1016/j.semarthrit.2020.01.007. Epub 2020 Jan
2020
ASL Città di Torino

Cuadrado MJ; Sciascia S; Roccatello D; Rubini E; Schreiber K; Cecchi I; Radin M;

2020
ASL Città di Torino

de Andrade DCO; Sciascia S; Gândara APR; Radin M; Nascimento IS;

Hydroxychloroquine reduces IL-6 and pro-thrombotic status. in Autoimmunity reviews / Autoimmun Rev. 2020 Jul;19(7):102555. doi: 10.1016/j.autrev.2020.102555. Epub 2020 May 12.
2020
ASL Città di Torino

Stach K; Krämer BK; Roccatello D; Radin M; Schreiber K; Sciascia S;

Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. in European journal of rheumatology / Eur J Rheumatol. 2020 Jan 1;7(1):31-34. doi: 10.5152/eurjrheum.2019.19141. Print 2020 Jan.
2020
ASL Città di Torino

Sciascia S; Radin M; Cuadrado MJ; Roccatello D; Massaglia S; Heffler E; Peano C; Padovan D; Gilcrease GW;

Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring. in Autoimmunity reviews / Autoimmun Rev. 2020 Feb;19(2):102449. doi: 10.1016/j.autrev.2019.102449. Epub 2019 Dec 12.
2020
ASL Città di Torino

Roccatello D; Menegatti E; Alba P; Escudero A; Foddai SG; Rubini E; Guiñazu F; Ladehesa PL; Radin M; Rossi D; Massara C; Cecchi I; Sciascia S;

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies. in Biomedicines / Biomedicines. 2020 Dec 17;8(12):622. doi: 10.3390/biomedicines8120622.
2020
ASL Città di Torino

Sciascia S; Roccatello D; Mahler M; Seaman A; Ramirez C; Barinotti A; Rubini E; Foddai SG; Cecchi I; Radin M;

Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing. in International journal of molecular sciences / Int J Mol Sci. 2020 Dec 15;21(24):9551. doi: 10.3390/ijms21249551.
2020
ASL Città di Torino

Menegatti E; Sciascia S; Roccatello D; Rubini E; Foddai SG; Cecchi I; Radin M; Barinotti A;

Treatment of antiphospholipid syndrome. in Clinical immunology (Orlando, Fla.) / Clin Immunol. 2020 Dec;221:108597. doi: 10.1016/j.clim.2020.108597. Epub 2020 Sep 19.
2020
ASL Città di Torino

Sciascia S; Menegatti E; Roccatello D; Barinotti A; Rubini E; Foddai SG; Radin M; Cecchi I;

Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. in Journal of nephrology / J Nephrol. 2020 Aug;33(4):757-762. doi: 10.1007/s40620-019-00698-9. Epub 2020 Jan 23.
2020
ASL Città di Torino
ASL Torino 5

Roccatello D; Rubini E; Miraglia P; Besso L; Baldovino S; Rossi D; De Marchi A; Fenoglio R; Cecchi I; Sciascia S; Radin M;

Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome. in Thrombosis and haemostasis / Thromb Haemost. 2020 Apr;120(4):592-598. doi: 10.1055/s-0040-1705115. Epub 2020 Mar 17.
2020
ASL Città di Torino

Sciascia S; Bertolaccini ML; Roccatello D; Schreiber K; Rubini E; Cecchi I; Foddai SG; Radin M;

2020
ASL Città di Torino

Lopez-Pedrera C; Menegatti E; Roccatello D; Aguirre Zamorano MA; Patiño Trives AM; Perez-Sanchez L; Scudeler L; Barbarroja Puerto N; Arias de la Rosa I; Radin M; Sciascia S; Perez-Sanchez C; Cecchi I;

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion. in Journal of cellular and molecular medicine / J Cell Mol Med. 2019 Sep;23(9):6308-6318. doi: 10.1111/jcmm.14517. Epub 2019 Jul 26.
2019
ASL Città di Torino

Collantes E; López-Pedrera C; Aguirre MÁ; Sciascia S; Roccatello D; Radin M; Castro MC; Escudero A; Ortega R; Ibáñez-Costa A; Arias de la Rosa I; Luque-Tévar M; Pérez-Sánchez L; Barbarroja N; Patiño-Trives AM; Cecchi I; Pérez-Sánchez C;

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2019 Oct 1;58(10):1870-1872. doi: 10.1093/rheumatology/kez166.
2019
ASL Città di Torino

López Pedrera C; Roccatello D; Collantes E; Sciascia S; Menegatti E; Barbarroja N; Pérez-Sánchez C; Aguirre MÁ; Rubini E; Cecchi I; Radin M; Arias de la Rosa I;

The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience. in European journal of internal medicine / Eur J Intern Med. 2019 Oct;68:e12-e14. doi: 10.1016/j.ejim.2019.07.026. Epub 2019 Aug 2.
2019
ASL Città di Torino
AOU Città della Salute di Torino

Cecchi I; Mengozzi G; Roccatello D; Sciascia S; Radin M;

Pregnancy outcomes in mixed connective tissue disease: a multicentre study. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2019 Nov 1;58(11):2000-2008. doi: 10.1093/rheumatology/kez141.
2019
ASL Città di Torino

Sciascia S; Marozio L; Roccatello D; Benedetto C; Aguirre MA; Izmirly P; Buyon J; Khamashta M; Gibbone E; Andrade D; Caleiro T; Franceschini F; Andreoli L; Cecchi I; Cuadrado MJ; Schreiber K; Radin M;

Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. in Annals of the rheumatic diseases / Ann Rheum Dis. 2019 Jul;78(7):1004-1006. doi: 10.1136/annrheumdis-2018-214559. Epub 2018 Dec 14.
2019
ASL Città di Torino

Roccatello D; Papotti M; Schreiber K; Barreca A; Cuadrado MJ; Aggarwal I; Radin M; Fenoglio R; Dall'Era M; Yazdany J; Sciascia S;

Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2019 Feb;48(4):741-744. doi: 10.1016/j.semarthrit.2018.04.001. Epub 2018 Apr
2019
ASL Città di Torino

Roccatello D; Bazzan M; Rubini E; Cecchi I; Radin M; Sciascia S;

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2019 Dec;49(3):464-468. doi: 10.1016/j.semarthrit.2019.04.009. Epub 2019 May
2019
ASL Città di Torino

Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D; Rossi Gandara AP; Borges Gualhardo Vendramini M; Willis R; Gonzalez E; Lopez-Pedrera R; Atsumi T; Knight JS; Rodriguez E; Rodriguez-Pinto I; Petri M; Andreoli L; Fortin PR; Branch DW; Ramires de Jesús G; Cohen H; Belmont HM; Ji L; Meroni P; Ugarte A; Tektonidou MG; Pengo V; Erkan D; et alii...

Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study. in Thrombosis and haemostasis / Thromb Haemost. 2019 Dec;119(12):1920-1926. doi: 10.1055/s-0039-1696687. Epub 2019 Oct 6.
2019
ASL Città di Torino

Aguirre Zamorano MÁ; Cecchi I; Sciascia S; Roccatello D; Schreiber K; Radin M; Cuadrado MJ;

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. in Frontiers in immunology / Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.
2019
ASL Città di Torino
AOU Città della Salute di Torino
AOU Novara

Mahler M; Vaccarino A; Ferro M; Baldovino S; Muccini E; Pergolini P; Mengozzi G; Montaruli B; Rolla R; Scotta A; Rubini E; Radin M; Cecchi I; Sciascia S; Menegatti E; Roccatello D;

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients. in Frontiers in medicine / Front Med (Lausanne). 2019 Sep 26;6:211. doi: 10.3389/fmed.2019.00211. eCollection 2019.
2019
ASL Città di Torino

Roccatello D; Rodríguez-Carrio J; Suárez A; Rubini E; Radin M; Cecchi I; Sciascia S;

Thrombotic antiphospholipid syndrome. in Lupus / Lupus. 2018 Oct;27(1_suppl):21-27. doi: 10.1177/0961203318801686.
2018
ASL Città di Torino

Radin M; Sciascia S;

Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients. in Thrombosis research / Thromb Res. 2018 Oct;170:28-31. doi: 10.1016/j.thromres.2018.07.031. Epub 2018 Aug 2.
2018
ASL Città di Torino

Mahler M; Sciascia S; Roccatello D; Schreiber K; Rubini E; Cecchi I; Radin M;

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. in Annals of the rheumatic diseases / Ann Rheum Dis. 2018 Nov;77(11):1694-1695. doi: 10.1136/annrheumdis-2018-213496. Epub 2018 May 18.
2018
ASL Città di Torino

Roccatello D; Rossi D; Cecchi I; Radin M; Rubini E; Sciascia S;

Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris. in BMJ case reports / BMJ Case Rep. 2018 May 30;2018:bcr2017223302. doi: 10.1136/bcr-2017-223302.
2018
ASL Città di Torino

Sciascia S; Baldovino S; Roccatello D; Radin M;

Prevalence and Thrombotic Risk Assessment of Anti-?2 Glycoprotein I Domain I Antibodies: A Systematic Review. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2018 Jul;44(5):466-474. doi: 10.1055/s-0037-1603936. Epub 2017 Aug 4.
2018
ASL Città di Torino

Sciascia S; Meroni PL; Roccatello D; Cecchi I; Radin M;

Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology. in European journal of rheumatology / Eur J Rheumatol. 2018 Jul;5(2):92-95. doi: 10.5152/eurjrheum.2018.17105. Epub 2018 Jan 22.
2018
ASL Città di Torino

Sciascia S; Radin M; Unlu O; Erkan D; Roccatello D;

Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort. in Lupus / Lupus. 2018 Jul;27(8):1393-1394. doi: 10.1177/0961203317751645. Epub 2018 Jan 11.
2018
ASL Città di Torino

Menegatti E; Baldovino S; Sandrone M; Radin M; Solfietti L; Naretto C; Bazzan M; Rossi D; Sciascia S; Roccatello D;

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"? in Journal of investigative medicine high impact case reports / J Investig Med High Impact Case Rep. 2018 Feb 15;6:2324709618758347. doi: 10.1177/2324709618758347.
2018
ASL Città di Torino

Sciascia S; Bertero L; Roccatello D; Radin M;

The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study. in European journal of neurology / Eur J Neurol. 2018 Feb;25(2):320-325. doi: 10.1111/ene.13499. Epub 2017 Dec 2.
2018
ASL Città di Torino

Cuadrado MJ; Cecchi I; Roccatello D; Schreiber K; Radin M; Sciascia S;

Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management. in Seminars in arthritis and rheumatism / Semin Arthritis Rheum. 2018 Aug;48(1):117-120. doi: 10.1016/j.semarthrit.2017.12.006. Epub 2018 Jan
2018
ASL Città di Torino

Andrade D; Sciascia S; Ugolini-Lopes MR; Radin M;

Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2018 Apr 1;57(4):661-665. doi: 10.1093/rheumatology/kex466.
2018
ASL Città di Torino

Bertolaccini ML; Cecchi I; Roccatello D; Radin M; Sanna G; Sciascia S;

Recent advances in the management of systemic lupus erythematosus. in F1000Research / F1000Res. 2018 Jun 29;7:F1000 Faculty Rev-970. doi: 10.12688/f1000research.13941.1. eCollection 2018
2018
ASL Città di Torino

Sanna G; Bertolaccini ML; Roccatello D; Radin M; Sciascia S;

2018
ASL Città di Torino
AOU Città della Salute di Torino

Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Vaccarino A; Roccatello D; Sciascia S; Batticciotto A; Prato G; Antivalle M; Ditto MC; Agosti M; Cumbo E; Talotta R; Atzeni F; Sarzi-Puttini P;

Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion? in Autoimmunity reviews / Autoimmun Rev. 2017 Nov;16(11):1109-1114. doi: 10.1016/j.autrev.2017.09.004. Epub 2017 Sep 9.
2017
ASL Città di Torino

Cervera R; Meroni PL; López-Pedrera C; Espinosa G; Bertolaccini ML; Coloma-Bazán E; Radin M; Sciascia S; Cuadrado MJ;

Antiphospholipid antibodies negativization: time for testing for non-criteria aPL? in Lupus / Lupus. 2017 Nov;26(13):1457-1458. doi: 10.1177/0961203317711014. Epub 2017 May 22.
2017
ASL Città di Torino

Pérez-Sánchez C; Cecchi I; Radin M;

Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review. in Autoimmunity reviews / Autoimmun Rev. 2017 May;16(5):469-477. doi: 10.1016/j.autrev.2017.03.008. Epub 2017 Mar 7.
2017
ASL Città di Torino

Sciascia S; Roccatello D; Almarzooqi AM; Al-Saleh J; Radin M; Leone A; Khamashta M;

Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. in Autoimmunity reviews / Autoimmun Rev. 2017 Mar;16(3):287-293. doi: 10.1016/j.autrev.2017.01.010. Epub 2017 Jan 29.
2017
ASL Città di Torino

Sciascia S; Radin M; Yazdany J; Levy RA; Roccatello D; Dall'Era M; Cuadrado MJ;

Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials. in Clinical drug investigation / Clin Drug Investig. 2017 Jun;37(6):519-524. doi: 10.1007/s40261-017-0518-z.
2017
ASL Città di Torino

Cuadrado MJ; Radin M; Roccatello D; Sciascia S; Mompean E;

Antiphospholipid antibodies: crossroads between autoimmunity and infections? in Internal and emergency medicine / Intern Emerg Med. 2017 Jun;12(4):557-558. doi: 10.1007/s11739-017-1664-2. Epub 2017 Apr 12.
2017
ASL Città di Torino

Roccatello D; Sciascia S; Radin M; Bazzan M;

Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome. in Internal and emergency medicine / Intern Emerg Med. 2017 Feb;12(1):1-7. doi: 10.1007/s11739-016-1596-2. Epub 2017 Jan 2.
2017
ASL Città di Torino

Sciascia S; Radin M; Bazzan M; Roccatello D;

Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review. in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy / BioDrugs. 2017 Feb;31(1):37-49. doi: 10.1007/s40259-016-0206-1.
2017
ASL Città di Torino

Cuadrado MJ; Roccatello D; Sciascia S; Radin M;

Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents. in Internal and emergency medicine / Intern Emerg Med. 2017 Dec;12(8):1101-1108. doi: 10.1007/s11739-017-1753-2. Epub 2017 Sep 19.
2017
ASL Città di Torino

Fenoglio R; Baldovino S; Radin M; Schreiber K; Sciascia S; Roccatello D;

Current insights in obstetric antiphospholipid syndrome. in Current opinion in obstetrics & gynecology / Curr Opin Obstet Gynecol. 2017 Dec;29(6):397-403. doi: 10.1097/GCO.0000000000000406.
2017
ASL Città di Torino

Schreiber K; Radin M; Sciascia S;

The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study. in Oncotarget / Oncotarget. 2017 May 23;8(32):52072-52077. doi: 10.18632/oncotarget.18120. eCollection 2017 Aug 8.
2017
ASL Città di Torino

Menegatti E; Baldovino S; Fenoglio R; Radin M; Naretto C; Alpa M; Sciascia S; Rossi D; Roccatello D;

The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction. in International journal of cardiology / Int J Cardiol. 2017 Aug 1;240:72-77. doi: 10.1016/j.ijcard.2017.02.155. Epub 2017 Mar 24.
2017
ASL Città di Torino

Sciascia S; Bazzan M; Cuadrado MJ; Baldovino S; Roccatello D; Radin M; Schreiber K; Costanzo P; Cecchi I;

Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence. in Rheumatology international / Rheumatol Int. 2017 Aug;37(8):1249-1255. doi: 10.1007/s00296-017-3686-5. Epub 2017 Mar 3.
2017
ASL Città di Torino

Dall'Era M; Roccatello D; Cecchi I; Tektonidou M; Yazdany J; Sciascia S; Radin M;

2017
ASL Città di Torino

Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E;

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay. in Clinical and molecular allergy : CMA / Clin Mol Allergy. 2016 Jul 15;14:6. doi: 10.1186/s12948-016-0043-2. eCollection 2016.
2016
ASL Città di Torino

Roccatello D; Menegatti E; Erkan D; Cuadrado MJ; Radin M; Schreiber K; Solfietti L; Baldovino S; Sciascia S;

2016
ASL Città di Torino

Cabras M; Arduino PG; Sciascia S; Radin M; Solfietti L; Di Simone D; Giancaspero K; Menegatti E; Baldovino S;